Compare · head to head
IDEAYA Biosciences vs Relay Therapeutics
Relay Therapeutics ranks higher overall — 360 rank 23 vs 18.
IDEAYA Biosciences leads on Value (46 vs 37), Quality (54 vs 41) and Sentiment (53 vs 46). Relay Therapeutics leads on Growth (54 vs 34) and Safety (43 vs 28).
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | USA | USA |
| Sector | Health Care | Health Care |
| Industry | Biotechnology | Biotechnology |
| Size | Small | Small |
| ISIN | US45166A1025 | US75943R1023 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 18 | 23 |
| Value | 46 | 37 |
| Quality | 54 | 41 |
| Growth | 34 | 54 |
| Safety | 28 | 43 |
| Sentiment | 53 | 46 |
| Quality details | ||
| Profitability | 50 | 31 |
| Cash Truth | 57 | 50 |
Full analyses: IDEAYA Biosciences · Relay Therapeutics
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100